Silicon Biosystems Circulating Tumor Cell Capture Technologies Expand in 2018 Premium Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment. Menarini Silicon Biosystems Publishes Single-Cell WGA Liquid Biopsy Workflow, Eyes Clinical Market Premium The firm is also working on expanding its CTC capture capabilities beyond epithelial cells and will present multiple myeloma applications at an upcoming conference. Menarini-Silicon Biosystems Completes Acquisition of Janssen CTC System The purchase from Janssen of a liquid biopsy test for circulating tumor cells marks Menarini-Silicon's entry into the US diagnostics market. Menarini-Silicon Biosystems to Acquire Cellsearch CTC Platform From Janssen Diagnostics Cellsearch is the only FDA-cleared circulating tumor cell test and is used to help manage patients with metastatic breast, prostate, and colorectal cancers. Macrogen, Silicon Biosystems Menarini Ink Deal to Co-Develop CLIA-Certified Cancer Assays They plan to combine Silicon’s DEPArray digital-sorting technology with Macrogen’s NGS systems to develop genomic tests for different cancers. Feb 10, 2016 Silicon Biosystems, Swift Ink Deal to Join NGS, Tumor Cell Isolation Technologies Oct 30, 2013 NCI Awards Contract to PGXL for CTC Research Sep 24, 2013 In Menarini Deal, Silicon Bio Sees Opportunities for Clinical Validation, Menu Expansion Premium Sep 12, 2013 Italy's Menarini Acquires Cell Array Firm Silicon Biosystems Apr 25, 2013 PGXL, Silicon Biosystems Partner on DEPArray Technology Feb 26, 2013 IP Roundup: Caltech, U of California, Rheonix, Roche NimbleGen, Silicon Biosystems, and More Premium Jun 1, 2012 In Brief This Week: Transgenomic; Fluxion Biosciences; Silicon Biosystems; DNA Genotek; Annai Systems Dec 6, 2011 Baylor Taps Silicon Bio DEPArray Platform for Potential Use in Prenatal Diagnostics Premium Sep 20, 2011 Fox Chase Cancer Center Adopts Silicon Bio's DEPArray Platform for Cancer Studies Premium Dec 14, 2010 Italy's Silicon Biosystems Opens US Office to Sell DEPArray Cell-Analysis Platform Premium Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.